Riik: Suurbritannia
keel: inglise
Allikas: MHRA (Medicines & Healthcare Products Regulatory Agency)
Liothyronine sodium
Morningside Healthcare Ltd
H03AA02
Liothyronine sodium
20microgram
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 06020100; GTIN: 5055132716041
Each tablet contains 20 micrograms liothyronine sodium. Also contains lactose. See leaflet for further information. To be taken by mouth. Use as directed by your doctor. Keep out of the sight and reach of children. Protect from light. Marketing Authorization Holder: Mercury Pharma Group Ltd., Capital House, 85 King William Street, London EC4N 7BL, UK LIOTHYRONINE SODIUM 20 MICROGRAMS TABLETS 28 Tablets 20 MICROGRAMS LL-119309-01 Peel here to read leaflet PL10972/0033 POM K L : n o i s r e V : y b d e s i v e R L 100201/LB/4, 100201/LF/4 M CRF No.: C AMCo.CRF.260.2014 M : e d o c r a B : e g a k c a P e r a w t f o S U 5021691 108528 M Dimensions: Pharma Code: 5 Key Line: P READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor, pharmacist or nurse. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. suitable oral syringe to withdraw the amount of liquid corresponding to the dose prescribed (5mL for a 5mcg dose; 10 mL for a 10mcg dose) and squirt the liquid directly into your mouth by gently pressing the plunger • Any remaining liquid should be discarded. ADULTS: The dose will depend upon your condition, ranging from 10 micrograms to 60 micrograms daily in divided doses. CHILDREN AND ELDERLY: The dose may be started at 5 micrograms a day. Please note that your doctor will monitor your thyroid function regularly to make sure that you are given the right dose for your condition. The score line is not intended for breaking the tablet. IF YOU TAKE MORE LIOTHYRONINE SODIUM TABLETS THAN YOU SHOULD: This may cause agitation, confusion, headache, sweating and a rapid pulse. If you take too many tabl Lugege kogu dokumenti
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Tertroxin Tablets 20mcg Liothyronine Sodium BP 20micrograms Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 20mcg liothyronine sodium BP. Excipient(s) with known effect: Lactose For the full list of excipients, see section 6.1. _ _ 3 PHARMACEUTICAL FORM Tablets The score line is not intended for breaking the tablet. See section 4.2. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Liothyronine sodium tablets are qualitatively similar in biological action to thyroxine but the effect develops in a few hours and lasts for 24 to 48 hours after stopping the treatment. Used for the treatment of coma of myxedema, the management of severe chronic thyroid deficiency and hypothyroid states occurring in the treatment of thyrotoxicosis. Liothyronine sodium can be used also in the treatment of thyrotoxicosis as an adjunct to carbimazole to prevent sub-clinical hypothyroidism developing during treatment. Liothyronine sodium may be preferred for treating severe and acute hypothyroid states because of its rapid and more potent effect, but thyroxine sodium is normally the drug of choice for routine replacement therapy. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology Adults: Starting dose of 10 or 20 micrograms every 8 hours, increasing after one week, if necessary, to the usual recommended daily dose of 60 micrograms in two or three divided doses. Myxedema Coma: 60 micrograms given by stomach tube, then 20 micrograms every 8 hours. It is more usual to start treatment with intravenous liothyronine. Adjunct to carbimazole treatment of thyrotoxicosis: 20 micrograms every 8 hours. Elderly and Children Patients: 5 micrograms daily. Method of Administration: Oral • For doses lower than 20 micrograms, the tablet should be allowed to dissolve/disperse in 20 mL of water for 10 minutes, in a small measuring cup. • The patient should gently swirl the solution occasionally to aid the dissolution/dispersion. The patient should then swirl the so Lugege kogu dokumenti